Chris Martin, Chairman and Non Executive Director of Myricx Bio said, “I am delighted to welcome Paolo to the board. He brings extensive leadership experience in R&D and commercialisation in the ...

Previously, this type of "class 1/4" antibody -- which attaches to two distinct areas or "epitopes" of the spike protein -- was only detected following natural infection from SARS-1. "This is ...

Antibodies are proteins that circulate in the blood and protect against foreign antigenic substances such as bacteria, viruses, fungi, parasites, chemicals, or toxins. They are Y-shaped structures ...

GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat: San Carlos, California Monday, O ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

The partnership aims to expedite the creation of precise treatments to improve results for solid tumour patients.

Global Bispecific Antibody Market Size Bispecific Antibodies Sales FDA Approved Bispecific Antibodies Market Forecast ...

Context Therapeutics is building up its bank of bispecific antibody candidates. | Context Therapeutics is building up its ...

SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, an innovative provider for life science solutions and tools, are excited to announce the release of their joint study ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

An Osaka Metropolitan University-led team has discovered an antibody that specifically binds to the food poisoning bacteria ...

The findings, from an international clinical trial, reinforce earlier findings of the benefits of the drug -- trastuzumab deruxtecan (T-DXd), an antibody-drug conjugate -- in these patients ...